| Journal Profile | |
| Journal Title | Tumori J
|
| Journal Title Abbreviations | TUMORI J |
| ISSN | 0300-8916 |
| E-ISSN | 2038-2529 |
| h-index | N.A. |
| CiteScore | | CiteScore | SJR | SNIP | CiteScore Rank |
|---|
| 2.40 | 0.453 | 0.603 | | Subject field | Quartiles | Rank | Percentile | Category: Medicine
Subcategory: Oncology | Q3 | 223 / 340 |
| Category: Medicine
Subcategory: Cancer Research | Q4 | 162 / 207 |
|
|
|
| Self-Citation Ratio (2019-2020) | 7.10% |
| Official Website | https://journals.sagepub.com/home/tmj |
| Online Manuscript Submission | https://uk.sagepub.com/en-gb/asi/tumori-journal/journal203463#submission-guidelines |
| Open Access | No |
| Publisher | |
| Subject Area | Medicine |
| Country/Area of Publication | Italy |
| Publication Frequency | |
| Year Publication Started | 0 |
| Annual Article Volume | 70 |
| Indexing (SCI or SCIE) | Science Citation Index
Science Citation Index Expanded
|
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0300-8916%5BISSN%5D |
| Average Duration of Peer Review * | Authorized Data from Publisher:
Data from Authors: |
| Competitiveness * | Data from Authors: |
| Useful Links | |
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
